Robert J Coury

Job Title Chairman
Country Netherlands
Current Employer Mylan

Robert J. Coury is the Chairman of Mylan N.V. Under his visionary leadership, Mylan has transformed from the third largest generics pharmaceutical company in the U.S. into one of the largest pharmaceutical companies in the world, earning spots in both the S&P 500 and, prior to the company’s reincorporation outside of the U.S. in 2015, the Fortune 500. 

Coury was first elected to Mylan’s board of directors in February 2002, having served since 1995 as a strategic advisor to the company. He became the board’s vice chairman shor

Robert J. Coury is the Chairman of Mylan N.V. Under his visionary leadership, Mylan has transformed from the third largest generics pharmaceutical company in the U.S. into one of the largest pharmaceutical companies in the world, earning spots in both the S&P 500 and, prior to the company’s reincorporation outside of the U.S. in 2015, the Fortune 500. 

Coury was first elected to Mylan’s board of directors in February 2002, having served since 1995 as a strategic advisor to the company. He became the board’s vice chairman shortly after his election, and served as CEO from September 2002 until January 2012. Coury then served as executive chairman from 2012 until he became chairman in June 2016.

Since 2007, Coury has led the company through a series of transactions totaling more than $25 billion, which transformed Mylan into a global powerhouse within the highly competitive pharmaceutical industry. The company has a workforce of more than 35,000 and sells products in more than 165 countries.

During this period of expansion, the company built an unmatched, high quality foundation for the future supporting Mylan’s mission of providing the world’s 7 billion people with access to high quality medicine and benefiting patients, customers, investors, and other stakeholders. 

Coury is also the founder and president of the Robert J. Coury Family Foundation, which is a charitable organization formed to help support his philanthropic efforts and his mission of giving back. He has served as a member of the University of Southern California President's Leadership Council since 2014. 

tly after his election, and served as CEO from September 2002 until January 2012. Coury then served as executive chairman from 2012 until he became chairman in June 2016.

Since 2007, Coury has led the company through a series of transactions totaling more than $25 billion, which transformed Mylan into a global powerhouse within the highly competitive pharmaceutical industry. The company has a workforce of more than 35,000 and sells products in more than 165 countries.

During this period of expansion, the company built an unmatched, high quality foundation for the future supporting Mylan’s mission of providing the world’s 7 billion people with access to high quality medicine and benefiting patients, customers, investors, and other stakeholders. 

Coury is also the founder and president of the Robert J. Coury Family Foundation, which is a charitable organization formed to help support his philanthropic efforts and his mission of giving back. He has served as a member of the University of Southern California President's Leadership Council since 2014.